Enterprise Value
9.516M
Cash
20.23M
Avg Qtr Burn
-10.28M
Short % of Float
4.95%
Insider Ownership
43.25%
Institutional Own.
4.51%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NE3107 Details Alzheimer's disease | Phase 3 Update | |
NE3107 Details Parkinson's disease | Phase 3 Initiation | |
BIV201 Details Ascites | Phase 2b Update |